Kenji Hashimoto

3PUBLICATIONS
39CO-AUTHORS
Medical physicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 08, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PET.

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|Jun 02, 2021
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development.

Kenji Hashimoto

Pageof 1

Frequent Collaborators

2 joint publications

Elisabeth Ge de Vries

2 joint publications

Kevin Duffy

2 joint publications

Philip Bland-Ward

2 joint publications

Daan G Knapen